Tele-Harm Reduction

Tele-Harm Reduction for Rapid Initiation of Antiretrovirals in People Who Inject Drugs: a Randomized Controlled Trial

The purpose of this study is to test 2 different methods for offering medications that treat HIV, cure Hepatitis C Virus (HCV) (if applicable) and treat substance use disorder (if desired) to people who inject drugs.

Inclusion Criteria:

• age 18 or older
• able to speak English
• enrolled in IDEA Miami or IDEA Tampa SSPs
• injection drug use in past 12 months by self-report
• willing and able to sign informed consent, provide locator information and medical records release
• testing reactive for HIV by rapid test
• HIV RNA>200 copies/ml as determined by on-site labs or abstracted medical records (result within 3 months of randomization date)

Exclusion Criteria:

• testing HIV negative via rapid test
• receipt of THR intervention in the past 6 months
• inability to provide informed consent
• planning to leave the area within 12 months
• Principal or site investigator discretion
• currently in prison or jail
• Enrollment in Clinical Trials Network 121